Assessing Technology of Cellular Senescence with Minimally Invasive Sampling Technique

NineSigma, representing Suntory Global Innovation Center Ltd. (“Client”), which serves as the Suntory Group's basic research department, seeks technologies for making a minimally invasive assessment of cellular senescence in the human clinical setting. The Client has in mind biomarker-based assessment methods but welcomes proposals for a wide range of other approaches.

Image credit: BruceBlaus/Wikipedia/CC BY-SA 4.0

Anti-ageing is one of the major targets in the research on functional food. By establishing technology for assessing cellular senescence based on a minimally invasive sampling technique, the Client aspires to advance the anti-ageing research in humans with a focus on food.

Possible approaches may include, but are not limited to:

  • Technology for biomarker-based assessment of cellular senescence
  • Fluorometric quantification based on staining for SA-βGal, γH2AX, etc.
  • Quantitative assessment of cellular senescence using image-processing technology

Submissions to this Challenge must be received by Feb 8, 2021.

Source: NineSights